Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Krag

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Neurology. Genetics|December 22, 2017
Clinical heterogeneity and phenotype/genotype findings in 5 families with <i>GYG1</i> deficiencyRabah Ben Yaou, Aurélie Hubert, Isabelle Nelson, et al.
Acta Neuropathologica Communications|October 30, 2019
Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairmentPascal Laforêt, Michio Inoue, Evelyne Goillot, et al.
Journal of Neuroimmunology|October 5, 2023
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravisSonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Neurology. Genetics|December 22, 2017
Clinical heterogeneity and phenotype/genotype findings in 5 families with <i>GYG1</i> deficiencyRabah Ben Yaou, Aurélie Hubert, Isabelle Nelson, et al.
Acta Neuropathologica Communications|October 30, 2019
Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairmentPascal Laforêt, Michio Inoue, Evelyne Goillot, et al.
Journal of Neuroimmunology|October 5, 2023
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravisSonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, et al.
Pageof 5